2008
Medical treatment options for leiomyomas
Bromer J, Arici A. Medical treatment options for leiomyomas. 2008, 109-122. DOI: 10.3109/9780203091425-11.Peer-Reviewed Original ResearchUterine myomaImportant public health problemReproductive-age womenMedical treatment optionsSubgroup of womenPreferred first lineCommon benign tumorPublic health problemMajority of casesAfrican American womenCertain ethnic populationsBowel dysfunctionPelvic painUrinary retentionConservative managementMenstrual abnormalitiesClinical entityTreatment optionsAge womenRisk factorsCaucasian womenCommon disorderBenign tumorsUterine leiomyomaMyomasMedical treatment options for endometriosis
Mahutte N, Arici A. Medical treatment options for endometriosis. 2008, 95-108. DOI: 10.3109/9780203091425-10.Peer-Reviewed Original ResearchReproductive-age womenMedical treatment optionsPrevious surgical incisionPosterior culDeep dyspareuniaPelvic painChocolate cystsEndometrial tissuePelvic sidewallTreatment optionsAge womenRectovaginal septumSurgical incisionUterosacral ligamentsEndometriosisDependent portionWomenDyspareuniaDysmenorrheaPainInfertilityLungUterusPelvisCysts
2005
Immunology of endometriosis.
Ulukus M, Arici A. Immunology of endometriosis. Minerva Obstetrics And Gynecology 2005, 57: 237-48. PMID: 16166933.Peer-Reviewed Original ResearchConceptsPathogenesis of endometriosisEctopic endometrial cellsEndometrial cellsAutoimmune diseasesImmune cellsNatural killer cell cytotoxicityPresence of autoantibodiesKiller cell cytotoxicityReproductive-age womenRetrograde menstruation theoryRetrograde menstruationCellular immunityHumoral immunityUterine cavityEctopic endometriumEndometriotic diseaseAge womenT cellsPeritoneal cavityEnigmatic disorderEndometriosisCell cytotoxicityImpaired capacityPathogenesisStromal cells